Evolution of the Therapeutic Care in Ovarian Cancer From 2011

Study of the Impact on Survival of a Paradigm Shift in the Therapeutic Strategy of Patients With Advanced Ovarian Cancer

NCT06907771 ·Status: RECRUITING

Skeletal Muscle Energy Metabolism in Women With Weight Loss and Ovarian and/or Endometrial Cancer With Weight Loss

NCT03027479 ·Status: COMPLETED ·Phase: NA

Registry Platform Ovarian and Endometrial Cancer

NCT05129969 ·Status: RECRUITING

Evaluation of Prognostic Factors for Tubo-ovarian Cancer in France

NCT05204342 ·Status: COMPLETED

Circulating Tumor DNA as an Early Marker of Recurrence and Treatment Efficacy in Ovarian Carcinoma

NCT03302884 ·Status: UNKNOWN ·Phase: NA

Impact of a Multidisciplinary Assessment in Day Hospitalization Versus Standard Care on the Deployment of Supportive Oncology Care Recommended by the Personalized Post-cancer Plan in Patients at the End of Initial Treatment for Gynecological Ovarian and Endometrial Cancer Endometrial Cancer

NCT06553612 ·Status: RECRUITING ·Phase: NA

Genomic BRCA and Extensive ovArian Cancer Testing

NCT04027868 ·Status: COMPLETED

Constitution of ex Vivo Ovarian Tumor Models for the Validation of the Interest of Innovative Therapies and the Search for Tumor or Circulating Biomarkers Predictive of Treatment Response

NCT03831230 ·Status: COMPLETED

Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers

NCT03976999 ·Status: RECRUITING ·Phase: NA

Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors

NCT04675320 ·Status: UNKNOWN

Evaluation of Chemotherapy Influence on Clinical and Biological Markers of Ovarian Reserve

NCT00712452 ·Status: TERMINATED ·Phase: NA

Elizabeth Registry for Low Grade Ovarian Cancer

NCT00345709 ·Status: COMPLETED

Study of Predictive Factors of Chemoresistance in Ovarian Cancer

NCT02878122 ·Status: COMPLETED

Institut Paoli Calmettes Ovarian Cancer Database

NCT02869568 ·Status: RECRUITING

Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer

NCT05872204 ·Status: RECRUITING ·Phase: PHASE2

Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging

NCT06084195 ·Status: RECRUITING ·Phase: NA

Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer

NCT05080556 ·Status: RECRUITING ·Phase: PHASE2

Platino-resistance in Ovarian Cancer

NCT03954171 ·Status: RECRUITING ·Phase: NA

Phenotypic Characterization Tumor-infiltrating Lymphocytes at Diagnosis and After Chemotherapy in Ovarian Cancer

NCT03922776 ·Status: TERMINATED ·Phase: NA

Microscopic Peritoneal Metastases After Complete Macroscopic Cytoreductive Surgery for Epithelial Ovarian Cancer

NCT03754569 ·Status: COMPLETED ·Phase: NA

French Observatory of Rare Malignant Tumors of the Ovary

NCT01304043 ·Status: COMPLETED

Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma

NCT00758732 ·Status: TERMINATED ·Phase: PHASE2

Impact of Systematic Imaging for Follow up of Patients With Ovarian, Fallopian Tube or Primary Peritoneum Cancer

NCT04826029 ·Status: WITHDRAWN ·Phase: NA

A Study of ABT-263 as Single Agent in Women With Platinum Resistant/Refractory Recurrent Ovarian Cancer

NCT02591095 ·Status: COMPLETED ·Phase: PHASE2

Study of Circulating Tumoral DNA in Ovarian Cancer

NCT01350908 ·Status: COMPLETED ·Phase: NA